NetworkNewsBreaks

TuesdayMar 05, 2024 2:46 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q4 and FY 2023 Results Call

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced that it will hold a conference call to discuss its results for the fourth quarter and full fiscal year ended Dec. 31, 2023. During the call, slated to begin at 4:30 p.m. ET on Wednesday, March 20, 2024, HeartBeam executives will also provide regulatory updates, reviewing ongoing initiatives and anticipated 2024 milestones. HeartBeam CEO and Founder Branislav Vajdic, PhD, President Robert Eno, Consulting CFO Richard Brounstein, and VP of Regulatory Affairs Deborah Castillo, PhD, will host the call, followed by…

Continue Reading

TuesdayMar 05, 2024 2:30 pm

NetworkNewsBreaks — SOBR Safe Inc. (NASDAQ: SOBR) Reports ‘Dual Adoption’ of Proprietary Technology as Existing Behavioral Health Customer Expands Use

SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, is collaborating with an existing behavioral health customer to expand the use of its proprietary SOBRsafe(TM) technology. SOBRSafe announced that the customer, which is not named for patient privacy reasons, has adopted the SOBRsure wearable band for continuous monitoring in an outpatient scenario; the customer had previously installed SOBRcheck in one of its facilities for point-of-care screening. “This customer is consistent with our approach to the behavioral health market — sign providers with multiple uses for our technology, prove its efficacy and expand within the account,” said SOBRsafe chair and…

Continue Reading

TuesdayMar 05, 2024 2:10 pm

NetworkNewsBreaks – Software Effective Solutions Corp. (SFWJ) Ideally Poised Amid Growing Evidence of Cannabis’ Benefits and Safety

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a global infrastructure and holding company in the cannabis industry, is paying close attention to growing data showing the power of cannabis. “One recent study, conducted by postdoctoral research fellow Thomas Arkell, a PhD at Swinburne University of Technology in Melbourne, Australia, suggests that medical cannabis treatment may be associated with improvements in health-related quality of life among patients with a range of health conditions. The results of the study were published earlier this year by JAMA Network Open… This is just one of innumerable studies focused on cannabis… ‘Based on evidence currently…

Continue Reading

TuesdayMar 05, 2024 1:55 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Presents Positive Results on First-in-Human Phase 1 Study of Lucid-MS

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announced its participation in Americas Committee for Treatment and Research in Multiple Sclerosis (“ACTRIMS”) 2024 Forum. Held during Feb. 29 - Mar 2, 2024, in West Palm Beach, Florida, the annual conference is the largest MS event of its kind in North America. Represented by its senior research and clinical development team and co-authored by several of its esteemed scientific advisors, FSD shared the results of its phase 1 clinical study. The results were displayed in a…

Continue Reading

TuesdayMar 05, 2024 1:35 pm

NetworkNewsBreaks – Zoned Properties Inc. (ZDPY) Marks Pivotal Step in Scaling D2C Real Estate Portfolio

Zoned Properties (OTCQB: ZDPY), a technology driven property investment company for emerging and highly regulated industries, including legalized cannabis, today announced that it has listed its cultivation property in Chino Valley, Arizona (the “Chino Valley Property”) for sale at a purchase price of $16 million. The potential transaction marks a significant development in the company’s strategic real estate portfolio optimization. “As part of our ongoing strategic review to enhance shareholder value, we are very pleased to announce our intention to sell our Chino Valley Property. The Chino Valley Property, which we now consider a non-core asset to our investment strategy,…

Continue Reading

TuesdayMar 05, 2024 1:09 pm

NetworkNewsBreaks – Sekur Private Data Ltd.’s (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0) Unparalleled Security Solutions Stop Attacks Before They Happen

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FRA: GDT0), a cybersecurity and internet privacy provider of Swiss-hosted solutions, offers a suite of secure cloud-based storage, disaster recovery, document management, encrypted email, and secure communication tools that do not rely on third-party cloud services. Sekur’s products include SekurMail(R) with SekurSend/SekurReply, SekurVPN (R), and SekurMessenger(R). “Sekur offers customers peace of mind – with all customer information remaining confidential and safely stored in Switzerland using military-grade security. All data, whether physical, network-based or encryption security, is stored in bank-approved, state-of-the-art ISO-certified data centers used by Swiss and global banks and most United Nations…

Continue Reading

MondayMar 04, 2024 2:38 pm

NetworkNewsBreaks – BioVie Inc. (NASDAQ: BIVI) to Secure ~$21M in Public Offering

BioVie (NASDAQ: BIVI) is a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders. The company today announced the pricing of its best efforts public offering of 21,000,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to 10,500,000 shares of common stock at a combined offering price of $1.00 per share (or pre-funded warrant) and associated warrant. The warrants will have an exercise price of $1.50 per share and will be immediately exercisable for a period of five years following the date…

Continue Reading

MondayMar 04, 2024 2:26 pm

NetworkNewsBreaks – Biofrontera Inc. (NASDAQ: BFRI) Closes on Private Placement Valued at Up to $16M

Biofrontera (NASDAQ: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, has closed on a securities purchase agreement. According to the announcement, the agreement is with healthcare-focused institutional investors led by Rosalind Advisors. The financing is for an initial $8 million with an additional $8 million second tranche, dependent on the company reaching specified milestones. The company noted that the funding, along with recent restructuring of a supply agreement, allow it to conduct planned research and development activities as well as support further commercial growth. “The company intends to use the upfront net proceeds from the private placement…

Continue Reading

MondayMar 04, 2024 1:05 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Weight-Loss Results in Animal Study, Begins Eight-Week Follow-Up Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting glucose reduction and weight-loss results in a testing of its wholly owned and patented DehydraTECH-CBD formulation. According to the announcement, when administered to rodents in an eight-week study, DehydraTech-CBD resulted in weight loss of 7% and a reduction of 19.9% (p<0.05) in blood glucose. As a result, Lexaria has now signed contracts to begin a large, multiweek animal study that will substantially progress its DehydraTECH-GLP-1 and DehydraTECH-CBD weight-loss investigations. In addition, the announcement also noted that the company had published results of a human study, which showed that a single…

Continue Reading

MondayMar 04, 2024 12:21 pm

NetworkNewsBreaks – Upstream Spotlights Its Dual Listing Program, Designed to Bridge the Gap Between International Investors and Companies

Upstream, a MERJ Exchange market and trading app, recently posted a blog article discussing the 12th episode of its “Upstream Up Close” series on Twitter Spaces. The series features 10–15 minute discussions on the exciting world of digital collectibles, Web3 and trading on the Upstream platform. Episode 12 delved into the Upstream Dual Listing Program. “[The program] is a key initiative offering companies that are listed on global stock exchanges such as NASDAQ, NYSE, OTC, Euronext, ASX, NSX, TSX, CSE etc., to dual list on Upstream and access a global investor base who can trade their shares from anywhere in…

Continue Reading